From Surf Wiki (app.surf) — the open knowledge base

Ebalzotan

Chemical compound

| elimination_half-life =

Ebalzotan (NAE-086) is a selective 5-HT1A receptor agonist. It was under development as an antidepressant and anxiolytic agent but produced undesirable side effects in phase I clinical trials and was subsequently discontinued.

References

(2008). "Process chemistry in the pharmaceutical industry, volume 2 challenges in an ever changing climate". CRC Press.
(2005). "Medicinal chemistry a molecular and biochemical approach". Oxford University Press.

Info: Wikipedia Source

This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.

amines carboxamides chromanes isopropylamino-compounds

Want to explore this topic further?

Ask Mako anything about Ebalzotan — get instant answers, deeper analysis, and related topics.

Research with Mako

Free with your Surf account

Content sourced from Wikipedia, available under CC BY-SA 4.0.

This content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.

Report